NCT06344091View on ClinicalTrials.gov

A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

May 21, 2024

Primary Completion Date

September 28, 2026

Study Completion Date

October 12, 2026

Conditions
Local Analgesia Via Infiltration
Interventions
DRUG

Bupivacaine Liposome Injection

Bupivacaine Liposome Injection 4 mg/kg (up to a maximum of 266 mg)

Trial Locations (1)

510000

RECRUITING

Guangzhou Women and Children's Medical Center, Guangzhou

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY